Digoxin Drug-Drug Interaction With Lurasidone HCl

Phase 1 Completed 24 enrolled Sumitomo Pharma America, Inc.

NaSingle-group

Summary

The objective of this study is to evaluate the pharmacokinetic profile of digoxin when administered alone and when administered with repeated dose of lurasidone 120mg.

Timeline

Start: 2008-09
Primary completion: 2008-10
Completion: 2008-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lurasidone	Small molecule	120 mg	—

Digoxin Drug-Drug Interaction With Lurasidone HCl

Summary

Timeline

Drugs

Indications